Lifestyles
Moderna and Merck Cancer Vaccine Cuts Melanoma Recurrence 42%
Moderna and Merck leak of melanoma vaccine trial prompts release of data showing 42% decrease in recurrence risk or death paired with Keytruda.
Total Apex Entertainment
Moderna
The latest Moderna stories, news and analysis from the Total Apex Entertainment team.